Hawke's Bay COVID-19 Vaccine Information

 

Local update:

377,427 COVID-19 vaccination doses have been administered in Hawke’s Bay with 139,654 people completing two doses. 90,237 booster vaccinations have also been given. Last week the region delivered 284 vaccinations.*

97% of the eligible population have had 1 dose of a vaccine. 95% have had two doses and 72% have had a booster.*

*All data to 16 May 2022. More information about the Hawke's Bay vaccination roll out can be found here 

 


Vaccinations for 5-11 year olds:

Parents and caregivers now have the opportunity to protect their children aged 5 to 11 against COVID-19 with the child version of the Pfizer vaccine.

As we have seen to date, the virus can be unpredictable. While COVID-19 generally has milder effects in children, with symptoms similar to a cold, some children become severely ill and require hospitalisation.

Like we have seen with adults, if your child is infected with COVID-19 they may transmit the virus to other people. Immunising 5 to 11-year-olds helps protect whānau members whose health makes them more vulnerable to COVID-19.

Parents are encouraged to make an informed choice and have their children vaccinated to protect them and those they love.

More information about vaccinations for 5-11 year olds can be found here.

 

Third Primary Dose for 5-11 year olds who are severely immuno-compromised children.

  • Severely immunocompromised children aged 5 to 11 can now receive a third primary dose of the Pfizer COVID-19 vaccine.
  • There are specific criteria for which children qualify for a third primary dose.  
  • The third primary dose must be prescribed by an authorised prescriber such as a medical practitioner or nurse practitioner. Appointments to discuss whether your child is eligible for a third primary dose are free.
  • Scripts for a third primary dose can be taken to any vaccination site. 
  • The third primary dose should be given 8 weeks after the second dose but may be given after 4 weeks depending on current or planned immunosuppressive therapies. 
  • People with known severe immunocompromise from disease or its treatment are encouraged to contact their GP or treating health professional to discuss the timing, prescription and administration of this additional dose of vaccine. 
  • The third primary dose is optional but recommended by the COVID-19 Vaccine Technical Advisory Group.
  • A third primary dose is also being offered to severely immunocompromised children in this age group overseas, including in Australia, the United States, Canada, and the United Kingdom.

 

In addition:

  • Individuals who are severely immunocompromised are at higher risk of severe outcomes from COVID-19, and might not produce a sufficiently strong immune response after two doses of the Pfizer COVID-19 vaccine. A third primary dose offers extra protection for the individual, and may help reduce the likelihood of them transmitting the virus to others.  
  • A prescription must be provided by a GP, nurse practitioner, or other treating health professional before people who are severely immunocompromised can be given a third primary dose. 
  • It’s recommended that parents or guardians of a severely immunocompromised child schedule an appointment with their usual health care professional who has access to the child’s medical records. This will help confirm whether the child qualifies for a third primary dose.  
  • Your child might be able to receive the third primary dose at the same time as their consultation – check with your prescriber to see if they offer the child Pfizer COVID-19 vaccine. 
  • The third primary dose should be given 8 weeks after the second dose but may be given after 4 weeks depending on current or planned immunosuppressive therapies. Talk to your child’s GP or specialist for advice on timing.
  • It is strongly encouraged that all household contacts of someone who is severely immunocompromised (regardless of their age) are up-to-date with their recommended COVID-19 vaccines to help provide indirect protection. 

 


Pfizer booster vaccinations:

People aged 18 and over can get a booster vaccination 3 months after their second dose. People 16 and 17 can get a booster 6 months after their second dose. Booster vaccinations are available at all participating vaccination clinics. (See what’s on where above). 

You can go to a walk-in clinic or book an appointment to get a booster online through www.bookmyvaccine.nz

We encourage anyone who had their second vaccination more than 3 months ago to get their booster as soon as possible.

Booster vaccinations are free for anyone in New Zealand aged 18 or older. For more information about COVID-19 booster vaccinations click here.

 


Information about vaccines

Pfizer COVID-19 vaccine

The Pfizer vaccine (Comirnaty) is an mRNA vaccine that contains the genetic code for an important part of the SARS-CoV-2 (COVID-19) virus called the ‘spike protein’. Spike proteins are the little projections on the surface of the virus. Pfizer is the main vaccine used in NZ. 

mRNA vaccines do not contain any of the virus that causes COVID-19, or any other live, dead or deactivated viruses.

The COVID-19 vaccine is given as an injection into the muscle of your upper arm. You’ll need two doses, at least 3 weeks apart. Booster vaccinations are also available 3 months following your second dose for 18+ (6 months for 16-17 year olds).

Read more about the Pfizer vaccine here.

Information for severely immunocompromised people, including how to access a third primary dose of the COVID-19 vaccine

A third primary dose of the COVID-19 vaccine has been recommended for severely immunocompromised individuals aged 12 and older. Individuals who are severely immunocompromised are at a higher risk of severe outcomes from COVID-19 and might not produce a sufficiently strong immune response after two doses of the Pfizer COVID-19 vaccine. A third primary dose may be beneficial and can be administered at least eight weeks after the second dose. For more information please visit https://www.health.govt.nz/our-work/diseases-and-conditions/covid-19-novel-coronavirus/covid-19-vaccines/covid-19-vaccine-health-advice/covid-19-vaccine-severely-immunocompromised-people  

AstraZeneca COVID-19 vaccine

The AstraZeneca COVID-19 vaccine is now available for people aged over 18 as an alternative option to the Pfizer.

  • AstraZeneca is a two dose viral vector vaccine with a 4-12 week gap between doses
  • There is no live SARS-CoV-2 virus in the vaccine
  • The AstraZeneca vaccine will only be available at a limited number of sites across the country as Pfizer is the main COVID-19 vaccine we are using in New Zealand
  • AstraZeneca could be suitable for those who cannot have the Pfizer vaccine (for medical reasons) or those who want another option
  • Bookings for the AstraZeneca can be made at www.bookmyvaccine.nz 
  • Pfizer vaccine is the recommended booster dose regardless of what vaccine was used for earlier doses in New Zealand or overseas. Anyone who has had a serious adverse reaction to a dose of the Pfizer vaccine should discuss options with their healthcare professional. A prescription is required for anyone to access AstraZeneca as a booster dose which can now be given to anyone aged 18 and older, 3 months after completion of their primary course. 
  • Read the Ministry of Health's pamphlet about AstraZeneca vaccine here.

More information about the AstraZeneca vaccine is available here.

 

Novavax COVID-19 vaccine

The Novavax COVID-19 vaccine (Nuvaxovid) has now been approved to be used as a primary vaccination course for people aged 18 and older in Aotearoa. The primary course of Novavax is two doses three weeks apart. 

  • The Pfizer COVID-19 vaccine continues to be the preferred COVID-19 vaccine. Novavax, alongside AstraZeneca provides New Zealanders with COVID-19 vaccination options
  • The Novavax vaccine is now available at a limitied number of Hawke's Bay vaccination sites by booking only (www.bookmyvaccine.nz) or by calling COVID Vaccination Healthline 0800 28 29 26
  • Novavax is a protein-based COVID-19 vaccine. The vaccine helps prevent you from getting infected and having COVID-19 symptoms, or severe illness
  • Novavax can be administered to people who have received a different COVID-19 vaccine as their first dose, and this should occur at least 28 days after the first dose of the other COVID-19 vaccine. 
  • You will require a prescription for your second dose if your first dose was not Novavax. 
  • You can get a prescription at the vaccinating Novavax clinic or prior to your appointment with your preferred GP. Visits to a GP for a Novavax prescription are free. 
  • There is currently insufficient data on the Novavax vaccine to recommend it during pregnancy. Pfizer remains the preferred vaccine option for this group. 
  • Novavax contains a non-infectious component on the surface of the SARS-CoV-2 virus, which induces a protective immune response when the body’s immune cells come into contact with it. 

 


Booking information

How to make (or manage) a booking:

Vaccinations are also available at some other general practices, local pharmacies, churches and marae, please see what's on where at the top of the page.


He pātai? Questions?

If you have any queries about the COVID-19 vaccine visit www.covid19.govt.nz.